Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

Cyclooxygenase-2 (COX-2) is overexpressed in lung cancer, especially in adenocarcinoma (ADC). Our aim was to determine the prognostic value of COX-2 on survival in patients with lung cancer. Studies evaluating the survival impact of COX-2 in lung cancer, published until December 2005, were selected....

Descripción completa

Detalles Bibliográficos
Autores principales: Mascaux, C, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360613/
https://www.ncbi.nlm.nih.gov/pubmed/16786043
http://dx.doi.org/10.1038/sj.bjc.6603226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360613/
https://www.ncbi.nlm.nih.gov/pubmed/16786043
http://dx.doi.org/10.1038/sj.bjc.6603226

Ejemplares similares